Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects
Clinical trial NCT04523571 · COMPLETED
Trial details
- NCT number
- NCT04523571
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-28
- Primary completion
- 2020-09-30
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.